Preoperative clinical features of reactivated of Graves’ orbitopathy after orbital decompression – (Eye 31, 643 (April 2017))
Preoperative clinical features of reactivated of Graves’ orbitopathy after orbital decompression Eye 31, 643 (April 2017). doi:10.1038/eye.2016.304 Authors: Y J Woo, J W Kim & J S Yoon
Report of 12-months efficacy and safety of intravitreal fluocinolone acetonide implant for the treatment of chronic diabetic macular oedema: a real-world result in the United Kingdom – (Eye 31, 650 (April 2017))
Report of 12-months efficacy and safety of intravitreal fluocinolone acetonide implant for the treatment of chronic diabetic macular oedema: a real-world result in the United Kingdom Eye 31, 650 (April 2017). doi:10.1038/eye.2016.301 Authors: F Alfaqawi, P L Lip, S Elsherbiny, R Chavan, A Mitra & B Mushtaq
Pseudodacryocystitis: paediatric case series of infected atypical ethmoid air cells masquerading as recurrent dacryocystitis – (Eye 31, 657 (April 2017))
Pseudodacryocystitis: paediatric case series of infected atypical ethmoid air cells masquerading as recurrent dacryocystitis Eye 31, 657 (April 2017). doi:10.1038/eye.2016.282 Authors: A Mohite, T Jenyon, B Manoj, S Sandramouli, K Foster, A Oates, A-L McDermott & M V Parulekar
Comments on ‘Confidence of ophthalmology trainees in the management of posterior capsule rupture and vitreous loss’ – (Eye 31, 661 (April 2017))
Comments on ‘Confidence of ophthalmology trainees in the management of posterior capsule rupture and vitreous loss’ Eye 31, 661 (April 2017). doi:10.1038/eye.2016.228 Authors: F Bishop & A F Spencer
Response to: Comments on ‘Confidence of ophthalmology trainees in the management of posterior capsule rupture and vitreous loss’ – (Eye 31, 661 (April 2017))
Response to: Comments on ‘Confidence of ophthalmology trainees in the management of posterior capsule rupture and vitreous loss’ Eye 31, 661 (April 2017). doi:10.1038/eye.2016.223 Authors: A M J Turnbull & S C Lash